Meitar represented NYSE-listed Covidien, a US medical device manufacture, in its acquisition of Given Imaging, a medical technology company that develops and manufactures the swallowable imaging capsules for endoscopy, for approximately $1 billion.
In July 2013, an Israeli court ruled in favor of the Bronner brothers, represented by Meitar, in a complex inheritance dispute with their siblings, which is a part of a broader dispute involving a worldwide diamond and real-estate business.
Our firm represented J.P Morgan Securities, Merrill Lynch and several other underwriters in the $127 million initial public offering by Wix.com, including both primary and secondary shares, on NASDAQ.
Meitar represented SanDisk in the defense of a motion to certify a class action relating to media players, leading to the dismissal of the action.
Meitar represented TASE-listed Evogene, a plant genomics company, in its $73.8 million initial public offering on the NYSE.
Meitar represented the directors and officers of Leadcom Integrated Solutions in opposing a motion to certify a NIS 115 million class action relating to an allegedly misleading prospectus. The court dismissed the motion, finding that the issue is not suitable for adjudication as a class action.
Meitar represented Amdocs in its approximately $120 million acquisition of Actix International Limited, a leading independent provider of software for mobile network optimization.
